10-QPeriod: Q2 FY1999

BRISTOL MYERS SQUIBB CO Quarterly Report for Q2 Ended Jun 30, 1999

Filed August 13, 1999For Securities:BMYCELG-RIBMYMP

Summary

Bristol Myers Squibb Co. (BMY) filed its quarterly report for the period ending June 29, 1999. The filing provides a snapshot of the company's financial health and operational performance during the second quarter of that year. While specific financial figures are not detailed in the provided excerpt, the report's filing indicates ongoing adherence to regulatory reporting requirements. Investors should look to the full 10-Q filing for detailed financial statements, including revenue, net income, cash flow, and balance sheet information, to assess the company's performance and make informed investment decisions. Key areas of interest for investors typically include revenue growth, profitability trends, debt levels, and cash generation. The full report would also contain management's discussion and analysis, which offers valuable insights into the company's strategies, risks, and future outlook. Understanding these elements is crucial for evaluating BMY's current financial standing and its potential for future value creation.

Key Highlights

  • 1Bristol Myers Squibb Co. (BMY) filed its quarterly report on August 12, 1999, for the period ending June 29, 1999.
  • 2The filing is a standard Form 10-Q, indicating compliance with SEC reporting obligations.
  • 3The provided text is a directory listing of the filing's components, not the detailed financial statements themselves.
  • 4Investors must access the full 10-Q document to find specific financial data such as revenue, earnings, and cash flows.
  • 5Management's Discussion and Analysis (MD&A) section, typically found in the full report, would offer insights into operational performance and future outlook.
  • 6The filing is relevant for understanding the financial position of BMY during the second quarter of 1999.

Frequently Asked Questions

This is a Form 10-Q, which is a quarterly report filed by public companies with the SEC. Its purpose is to provide investors with a continuation of the information contained in the company's latest annual report (10-K), including financial statements and management's discussion of financial condition and results of operations for the most recent fiscal quarter.

The provided text is a directory listing of the filing's components, not the full financial statements. To find the specific financial results, you would need to access the complete 10-Q filing document, likely available through the SEC's EDGAR database or the company's investor relations website.

Investors should focus on key metrics such as revenue growth, net income (profitability), earnings per share (EPS), cash flow from operations, and the company's balance sheet (assets, liabilities, and equity). Additionally, reading the 'Management's Discussion and Analysis' section is crucial for understanding trends, risks, and future strategies.

This date represents the end of the fiscal second quarter for Bristol Myers Squibb Co. in 1999. The 10-Q report provides financial and operational data covering the three months leading up to and including this date, as well as comparative data from previous periods.